Prognostic outcomes in Japanese patients with metastatic castration-sensitive prostate cancer: Comparative assessments between conventional androgen deprivation therapy (ADT) and ADT with novel androgen receptor signal inhibitor.

Hiromitsu WatanabeKeita NakaneKiyoshi Takahara Taku Naiki Takahiro YasuiRyoichi ShirokiTakuya KoieHideaki Miyake

Published in: International journal of urology : official journal of the Japanese Urological Association (2024)

Combined use of ARSIs with ADT could improve the prognostic outcomes of mCSPC patients, particularly those in the LATITUDE high-risk group, in real-world clinical practice in Japan.

Keyphrases

prostate cancer
clinical practice
end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
radical prostatectomy
peritoneal dialysis
type diabetes
patient reported outcomes
bone marrow
weight loss
patient reported